![]() |
Impact Areas
|
Home / Benefits of plant science / Biotechnology Benefits & Safety Database / Global Status of Commercialized Biotech/GM Crops: 2006 (ISAAA Briefs No 35)
Global Status of Commercialized Biotech/GM Crops: 2006 (ISAAA Briefs No 35) (2006)This paper is relevant to the Agronomic, Safety & Health Impact, Socio-Economic, Environmental, and Overview Documents categories in the following areas:
Abstract or Summary:In 2006, the first year of the second decade of commercialization of biotech crops 2006-2015, the global area
of biotech crops continued to climb for the tenth consecutive year at a sustained double-digit growth rate of
13%, or 12 million hectares (30 million acres), reaching 102 million hectares (252 million acres). This is a
historical landmark in that it is the first time for more than 100 million hectares of biotech crops to be grown
in any one year. In order to appropriately account for the use of two or three "stacked traits", that confer
multiple benefits in a single biotech variety, the 102 million hectares expressed as "trait hectares" is 117.7
million, which is 15% higher than the estimate of 102 million hectares. Download Global Status of Commercialized Biotech/GM Crops: 2006 (ISAAA Briefs No 35) * CropLife International gives full acknowledgement to the author and publisher of this article (see download for details). |